AnaptysBio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,615	1,358	403	570	884	961
Market Cap Growth	167.89%	236.68%	-29.18%	-35.53%	-8.03%	63.35%
Enterprise Value	1,653	1,059	32.2	194.84	460.19	432.09
Last Close Price	55.50	48.48	13.24	21.42	30.99	34.75
Forward PE	24.64	-	-	-	-	16.86
PS Ratio	7.15	5.79	4.42	33.21	85.90	15.21
PB Ratio	129.86	1.68	5.69	6.47	3.37	2.70
P/TBV Ratio	1.95	1.72	5.30	6.55	3.33	2.67
P/FCF Ratio	376.88	69.27	-	-	-	-
P/OCF Ratio	371.07	68.96	-	-	-	-
EV/Sales Ratio	7.11	4.51	0.35	11.36	44.74	6.84
EV/EBITDA Ratio	39.97	21.85	-	-	-	-
EV/EBIT Ratio	40.51	22.11	-	-	-	-
EV/FCF Ratio	374.82	53.99	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.20	0.18	0.07	0.05
Debt / EBITDA Ratio	0.33	0.29	-	-	-	-
Debt / FCF Ratio	3.09	0.72	-	-	-	-
Net Debt / Equity Ratio	-0.33	-0.37	-5.21	-4.24	-1.61	-1.48
Net Debt / EBITDA Ratio	-6.60	-6.14	3.23	2.28	3.68	9.38
Net Debt / FCF Ratio	-61.88	-15.17	2.72	3.07	5.70	11.15
Asset Turnover	0.67	0.55	0.19	0.03	0.02	0.12
Quick Ratio	7.49	8.94	9.38	10.62	16.99	34.10
Current Ratio	7.58	9.07	9.51	10.87	17.16	34.40
Return on Equity (ROE)	-3.25%	-3.01%	-182.71%	-93.44%	-41.62%	-15.35%
Return on Assets (ROA)	11.69%	11.15%	-24.56%	-30.94%	-18.37%	-10.72%
Return on Invested Capital (ROIC)	408.41%	132.91%	-284.60%	-192.81%	-102.29%	-135.60%
Return on Capital Employed (ROCE)	13.29%	12.54%	-26.94%	-32.91%	-19.01%	-11.10%
FCF Yield	0.27%	1.44%	-	-	-	-
Buyback Yield / Dilution	3.66%	-1.32%	-5.42%	4.41%	-2.68%	-0.47%
Total Shareholder Return	3.66%	-1.32%	-5.42%	4.41%	-2.68%	-0.47%

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q